ProCE Banner Activity

Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders

Slideset

The presentation will focus on tardive dyskinesia, clinical pearls to distinguish it from other drug-induced movement disorders, and how assessment of the impact of tardive dyskinesia can aid treatment decisions with first-line VMAT2 inhibitor therapy.

Released: September 27, 2022

Expiration: September 26, 2023

Share

Faculty

Stuart Isaacson

Stuart Isaacson, MD

Clinical Associate Professor of Neurology
FIU Herbert Wertheim College of Medicine
Miami, Florida
Director
Parkinsons Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Teva

Faculty Disclosure

Primary Author

Stuart Isaacson, MD

Clinical Associate Professor of Neurology
FIU Herbert Wertheim College of Medicine
Miami, Florida
Director
Parkinsons Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida

Stuart Isaacson, MD: consultant/advisor/speaker: Acadia, Neurocrine, Supernus, Teva.